METHOD OF PRODUCING RECOMBINANT HUMAN GLIAL FIBRILLARY ACIDIC PROTEIN AND THE PRODUCER STRAIN USED IN IT Russian patent published in 2024 - IPC C12N1/21 C12N15/70 C12N15/12 C12P21/02 

FIELD: biotechnology.

SUBSTANCE: recombinant strain of E. coli Origami 2 (DE3) pET28ahGFAP is proposed for the production of recombinant human glial fibrillary acidic protein (GFAP) for the use in diagnostic purposes, obtained by transforming the strain E. coli Origami 2 (DE3) with the plasmid pET28a-hGFAP, shown in Fig. 2. A method of producing recombinant human glial fibrillary acidic protein using the specified strain is also proposed.

EFFECT: invention provides the possibility of obtaining recombinant human glial fibrillary acidic protein.

2 cl, 4 dwg, 2 tbl, 6 ex